|
José Baselga
Josep Baselga i Torres, known in Spanish as José Baselga (3 July 1959 – 21 March 2021) was a Spanish medical oncologist and researcher focused on the development of novel molecular targeted agents, with a special emphasis in breast cancer. Through his career he was associated with the Memorial Sloan Kettering Cancer Center, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, and the Massachusetts General Hospital in their hematology and oncology divisions. He led the development of the breast cancer treatment Herceptin, a monoclonal antibody, that targets the HER2/neu, HER2 protein which is impacted in aggressive breast cancers. He served as Physician-in-Chief at the Memorial Sloan Kettering Cancer Center and was also the president of the American Association for Cancer Research. Early life Baselga was born on 3 July 1959, in Barcelona in Spain. He received his M.D. and Ph.D. degrees from the Autonomous University of Barcelona in 1982. He completed a f ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
Cerdanya
Cerdanya () or often La Cerdanya ( la, Ceretani or ''Ceritania''; french: Cerdagne; es, Cerdaña), is a natural comarca and historical region of the eastern Pyrenees divided between France and Spain. Historically it was one of the counties of Catalonia. Cerdanya has a land area of , divided almost evenly between Spain (50.3%) and France (49.7%). In 2001 its population was approximately 26,500, of whom 53% lived on Spanish territory. Its population density is 24 residents per km² (63 per sq. mile). The only urban area in Cerdanya is the cross-border urban area of Puigcerdà-Bourg-Madame, which contained 10,900 inhabitants in 2001. The area enjoys a high annual amount of sunshine – around 3,000 hours per year. For this reason, pioneering large-scale solar power projects have been built in several locations in French Cerdagne, including Font-Romeu-Odeillo-Via, the Themis plant near Targassonne, and Mont-Louis Solar Furnace in Mont-Louis. History Antiquity The first ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
